FDA Approved: DECITABINE — Supplemental Application (Mylan Institutional LLC)

View source ↗

Summary

FDA approved a supplemental application for decitabine (generic) submitted by Mylan Institutional LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndromes

Drugs mentioned

• Decitabine (Decitabine)

Snippet

SUPPL AP for DECITABINE (DECITABINE)